跳至主要内容
临床试验/NCT03016650
NCT03016650Unknown4 期

Opioid-sparing Effect of Intravenous Ibuprofen

Muharrem Ucar0 个研究点目标入组 80 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
80
主要终点
Morphine Consumption

研究概览

简要总结

The investigators aimed to evaluate tramadol-sparing effect of intravenous (IV) ibuprofen in patients undergoing percutaneous nephrolithotomy (PCNL).

详细描述

Eighty patients who will undergoing PCNL are randomized to intravenous paracetamol (n=40) and intravenous ibuprofen (n=40) groups. Patients will receive 100 mL of physiologic saline with 1 g IV paracetamol or 800 mg IV ibuprofen 30 minutes before the end of the operation and postoperatively 6, 12 and 18 hours after PCNL in the paracetamol and ibuprofen groups, respectively. Patients in both groups will receive intravenous tramadol with patient controlled analgesia device (PCA).

The visual analog scale (VAS) will used to evaluate pain intensity scores in the postoperative period.

Total tramadol consumption, mean VAS score in the 1, 8 and 24 hours, demographic variables, operative variables, and side effects will record.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study include 80 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-70 years who scheduled for percutaneous nephrolithotomy operation.

排除标准

  • chronic pain,
  • psychiatric disease,
  • renal dysfunction,
  • allergy to nonsteroidal anti-inflammatory drugs,
  • history of drug addiction,
  • pregnancy,
  • inability to use a patient controlled analgesia (PCA) device.

研究组 & 干预措施

Paracetamol

Active Comparator

Patients will receive 100 mL of physiologic saline with 1 g IV acetaminophen (paracetamol) 30 minutes before the end of the operation and postoperatively 6, 12 and 18 hours after percutaneous nephrolithotomy, respectively.

干预措施: Acetaminophen (Drug)

ibuprofen

Active Comparator

Patients will receive 100 mL of physiologic saline with 800 mg IV ibuprofen 30 minutes before the end of the operation and postoperatively 6, 12 and 18 hours after percutaneous nephrolithotomy, respectively.

干预措施: Ibuprofen (Drug)

结局指标

主要结局

Morphine Consumption

时间窗: postoperatively 24 hours

次要结局

  • Visual Analog Scale(postoperatively 30 minute, 2, 4, 6,12 and 24 hours)

研究者

发起方
Muharrem Ucar
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muharrem Ucar

Principal Investigator

Inonu University

相似试验

Opioid-sparing Effect of Intravenous Ibuprofen | 临床试验